Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis - PubMed (original) (raw)
doi: 10.1136/jnnp-2011-301782. Epub 2012 May 7.
Kazumoto Shibuya, Yasunori Sato, Sonoko Misawa, Saiko Nasu, Yukari Sekiguchi, Satsuki Mitsuma, Sagiri Isose, Yumi Fujimaki, Shigeki Ohmori, Shunsuke Koga, Satoshi Kuwabara
Affiliations
- PMID: 22566594
- DOI: 10.1136/jnnp-2011-301782
Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis
Kazuaki Kanai et al. J Neurol Neurosurg Psychiatry. 2012 Jul.
Abstract
Objective: The aim of this study was to investigate whether axonal excitability indices are associated with survival in patients with amyotrophic lateral sclerosis (ALS). Previous nerve excitability studies suggested increased persistent sodium currents in motor axons of patients with ALS, which lead to axonal hyperexcitability and potentially enhance neuronal death.
Methods: 112 patients with sporadic ALS were followed up until endpoint (death or tracheostomy). Multivariate analyses were performed using the Cox proportional hazard model. Threshold tracking was used to measure multiple axonal excitability indices in median motor axons, such as strength-duration time constant (SDTC; a measure of nodal persistent sodium current). Latent addition was also used to estimate the magnitude of persistent sodium currents.
Results: The overall median tracheostomy-free survival from onset was 37 months. Prolonged SDTC was strongly associated with shorter survival (adjusted HR 4.07; 95% CI 1.7 to 9.8; p=0.0018) compared with older onset age (>60 years; HR=1.80) and bulbar onset (HR=1.80). Estimated median survival was 34 months in the longer SDTC group and 51 months in the shorter SDTC group. This index was highly statistically significant even after multiple testing adjustments with age and site of onset (bulbar or limb). Latent addition study results were consistent with these findings.
Conclusions: Axonal persistent sodium currents, estimated by SDTC and latent addition, are strong and independent predictors for shorter survival in patients with ALS. Membrane hyperexcitability is possibly associated with motor neuronal death, and modulation of excessive sodium currents could be a novel therapeutic option for ALS.
Similar articles
- [Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis].
Kanai K, Shibuya K, Kuwabara S. Kanai K, et al. Rinsho Shinkeigaku. 2011 Nov;51(11):1118-9. doi: 10.5692/clinicalneurol.51.1118. Rinsho Shinkeigaku. 2011. PMID: 22277502 Japanese. - Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis.
Iwai Y, Shibuya K, Misawa S, Sekiguchi Y, Watanabe K, Amino H, Kuwabara S. Iwai Y, et al. PLoS One. 2016 Jul 6;11(7):e0158596. doi: 10.1371/journal.pone.0158596. eCollection 2016. PLoS One. 2016. PMID: 27383069 Free PMC article. - Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons.
Shibuya K, Misawa S, Nasu S, Sekiguchi Y, Mitsuma S, Beppu M, Ohmori S, Iwai Y, Ito S, Kanai K, Sato Y, Kuwabara S. Shibuya K, et al. J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):969-72. doi: 10.1136/jnnp-2012-304109. Epub 2013 Mar 6. J Neurol Neurosurg Psychiatry. 2013. PMID: 23467416 - [Altered axonal ion channel function in amyotrophic lateral sclerosis].
Kuwabara S, Kanai K. Kuwabara S, et al. Brain Nerve. 2007 Oct;59(10):1109-15. Brain Nerve. 2007. PMID: 17969351 Review. Japanese. - [Amyotrophic lateral sclerosis--electrophysiologic aspects of its pathophysiology and new therapeutic options].
Kuwabara S. Kuwabara S. Brain Nerve. 2010 Aug;62(8):885-91. Brain Nerve. 2010. PMID: 20714037 Review. Japanese.
Cited by
- TDP43 autoregulation gives rise to shortened isoforms that are tightly controlled by both transcriptional and post-translational mechanisms.
Dykstra MM, Weskamp K, Gómez NB, Waksmacki J, Tank E, Glineburg MR, Snyder A, Pinarbasi E, Bekier M, Li X, Bai J, Shahzad S, Nedumaran J, Wieland C, Stewart C, Willey S, Grotewold N, McBride J, Moran JJ, Suryakumar AV, Lucas M, Tessier P, Ward M, Todd P, Barmada SJ. Dykstra MM, et al. bioRxiv [Preprint]. 2024 Jul 4:2024.07.02.601776. doi: 10.1101/2024.07.02.601776. bioRxiv. 2024. PMID: 39005384 Free PMC article. Preprint. - Selective vulnerability of motor neuron types and functional groups to degeneration in amyotrophic lateral sclerosis: review of the neurobiological mechanisms and functional correlates.
Ovsepian SV, O'Leary VB, Martinez S. Ovsepian SV, et al. Brain Struct Funct. 2024 Jan;229(1):1-14. doi: 10.1007/s00429-023-02728-6. Epub 2023 Nov 24. Brain Struct Funct. 2024. PMID: 37999738 Free PMC article. Review. - Biomarkers in amyotrophic lateral sclerosis: current status and future prospects.
McMackin R, Bede P, Ingre C, Malaspina A, Hardiman O. McMackin R, et al. Nat Rev Neurol. 2023 Dec;19(12):754-768. doi: 10.1038/s41582-023-00891-2. Epub 2023 Nov 10. Nat Rev Neurol. 2023. PMID: 37949994 Review. - Oxidative Stress as a Potential Mechanism Underlying Membrane Hyperexcitability in Neurodegenerative Diseases.
Pardillo-Díaz R, Pérez-García P, Castro C, Nunez-Abades P, Carrascal L. Pardillo-Díaz R, et al. Antioxidants (Basel). 2022 Aug 2;11(8):1511. doi: 10.3390/antiox11081511. Antioxidants (Basel). 2022. PMID: 36009230 Free PMC article. Review. - Acute retigabine-induced effects on myelinated motor axons in amyotrophic lateral sclerosis.
Sleutjes BTHM, Stikvoort García DJL, Kovalchuk MO, Heuberger JAAC, Groeneveld GJ, Franssen H, van den Berg LH. Sleutjes BTHM, et al. Pharmacol Res Perspect. 2022 Aug;10(4):e00983. doi: 10.1002/prp2.983. Pharmacol Res Perspect. 2022. PMID: 35881020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous